Washington Post Publisher Will Lewis Steps Down After Layoffs 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
SAN MATEO, Calif., Feb. 06, 2018 -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, will host a conference call on Wednesday, February 7, 2018 at 6:00pm EDT/Thursday, February 8, 2018 at 10:00am AEDT to discuss its Half Year Results to December 31, 2017.
Arik Anderson, Chief Executive Officer will host the call and will be joined by Adherium’s VP Finance and Business Services, Rob Turnbull, and Adherium’s Founder, Garth Sutherland.
Conference Call details:
Conference ID: 6589038
Dial-in Details:
Australia: 1800 123 296 or +61 2 8038 5221
New Zealand: 0800 452 782
Hong Kong: 800 908 865
United States: 1 855 293 1544
Webcast: http://www.openbriefing.com/OB/2812.aspx
For overseas participants, the conference call will commence at:
| - | 12:00pm on Thursday, February 8, 2018 | (New Zealand Daylight Time) | ||
| - | 7:00am on Thursday, February 8, 2018 | (Hong Kong Time) | ||
| - | 3:00pm on Wednesday, February 7, 2018 | (U.S. Pacific Daylight Time) | ||
| - | 6:00pm on Wednesday, February 7, 2018 | (U.S. Eastern Daylight Time) | ||
A recording of the call will be made available in the ‘Investor Centre’ section of the Company website at http://adherium.com/investors/ and at http://www.openbriefing.com/
About Adherium
Adherium is a provider of digital health solutions. The Company develops, manufactures and supplies patients, pharmaceutical companies, healthcare providers and contract research organizations with the broadest range of "smart" medication sensors for respiratory medications to address sub-optimal medication use and improve health outcomes in chronic disease. Adherium is headquartered in the USA, and operates globally from bases in the USA, Europe and Australasia.
Inquiries
United States:
Vik Panda, [email protected]
Leigh Salvo, Gilmartin Group, [email protected], +1 415 937 5404
Europe:
Scott Fleming, [email protected], +31 6 4687 6989
Australia:
Michael Brown, Pegasus Corporate Advisory, +61 400 248 080
Email:
[email protected]
Web:
www.adherium.com
